20114 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
#602Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
#603Bromocriptine formulations
#604PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION OF A MEDICAMENT
#605Solid preparation
#606Method for coating pharmaceutical substrates
#607Oral delivery system for hemoglobin based oxygen carriers
#608Solid pharmaceutical compositions of brown algae
#609ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
#610Pharmaceutical compositions
#611Naloxone single agent and multilayer tablets
#612PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM
#613Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
#614Abuse-resistant drug formulations with built-in overdose protection
#615Tablet formulation for CGRP active compounds
#616Composite formulation for oral administration comprising ezetimibe and rosuvastatin
#617Parenteral formulations of dopamine agonists
#618Modified release formulations of memantine oral dosage forms
#619Pharmaceutical composition containing clomipramine and preparation method therefor
#620Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#621Methylphenidate extended release chewable tablet
#622Modified release formulations containing drug-ion exchange resin complexes
#623Modified release formulations containing drug - ion exchange resin complexes
#624Controlled release and taste masking oral pharmaceutical composition
#625GASTRO-RETENTIVE ORAL PHARMACEUTICAL COMPOSITIONS
#626MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#627TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#628Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
#629Pharmaceutical compositions for minocycline
#630Modified Release Tranexamic Acid Formulation
#631Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
#632Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
#633Ferric citrate dosage forms
#634Osmotic drug delivery system
#635COMPOSITE FORMULATION COMPRISING TADALAFIL AND AMLODIPINE
#636Compressed tablet containing Δ9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
#637Thermo-kinetic mixing for pharmaceutical applications
#638Tamper resistant controlled release dosage forms
#639Encased tamper resistant controlled release dosage forms
#640Tamper resistant controlled release dosage forms
#641Tacrolimus for improved treatment of transplant patients
#642Modified release compositions comprising tacrolimus
#643Dosage forms for administering combinations of drugs
#644Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
#645Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#646Controlled release hydrocodone formulations
#647Abuse-proofed oral dosage form
#648COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION
#649PHARMACEUTICAL COMPOSITIONS CONTAINING REFAMETINIB
#650INTRAORALLY DISINTEGRABLE TABLET COMPRISING DISINTEGRABLE GRANULAR COMPOSITION
#651Methods and compositions for self-regulated release of active pharmaceutical ingredient
#652Extruded Immediate Release Abuse Deterrent Pill
#6533'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)
#654Benzonatate modified release solid tablets and capsules
#655Tamper-resistant tablet providing immediate drug release
#656Compositions of eltrombopag
#657Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
#658Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
#659Tamper-resistant pharmaceutical dosage forms and process for making same
#660TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE
#661Solid dispersions comprising tacrolimus
#662Modified release formulations containing drug-ion exchange resin complexes
#663Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation
#664Controlled release hydrocodone formulations
#665Controlled release hydrocodone formulations
#666Compositions and methods of using modified release solabegron for lower urinary tract symptoms
#667Encased tamper resistant controlled release dosage forms
#668Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
#669Controlled release hydrocodone formulations
#670Controlled release hydrocodone formulations
#671Controlled release hydrocodone formulations
#672Stable pharmaceutical compositions of thyroid hormone drug
#673Methylphenidate extended release chewable tablet
#674Stable pharmaceutical compositions comprising a pyrimidine-sulfamide
#675Cadotril particles
#676Acamprosate formulations, methods of using the same, and combinations comprising the same
#677Hot-melt extrusion of modified release multi-particulates
#678Controlled release formulations of levodopa and uses thereof
#679PHARMACEUTICAL PREPARATION COMPRISING PHENYLALANINE DERIVATIVE
#680DOSAGE FORMS FOR ORAL ADMINISTRATION OF ACTIVE SUBSTANCES
#681Pharmaceutical composition containing crystalline macitentan
#682Controlled-release melatonin compositions and related methods
#683PHARMACEUTICAL COMPOSITIONS OF TERIFLUNOMIDE
#684PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM
#685Guidewire/ partial occluder for intraluminal travel
#686Formulations of a bruton's tyrosine kinase inhibitor
#687Bromocriptine formulations
#688Solid dosage form of coated bisphosphonate particles
#689Osmotic drug delivery system
#690Solid pharmaceutical dosage form of dolutegravir
#691Dual drug dosage forms with improved separation of drugs
#692ABUSE-PROOFED ORAL DOSAGE FORM
#693Regimen for supressing organ rejection
#694Formulations of organic compounds
#695Benzonatate modified release solid tablets and capsules
#696Pharmaceutical compositions comprising Tadalafil
#697Methods and compositions for self-regulated release of active pharmaceutical ingredient
#698DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
#699Sustained-release solid preparation for oral use
#700Porous silica gel as a carrier for liquid technologies
#701HIGH DRUG LOAD PHARMACEUTICAL COMPOSITIONS WITH CONTROLLABLE RELEASE RATE AND PRODUCTION METHODS THEREOF
#702POSITIONING IMMEDIATE-RELEASE BIOADHESIVE AND APPLICATION THEREOF
#703ABUSE-PROOFED DOSAGE FORM
#704Prolonged-release diphenidol composition
#705Tamper resistant dosage forms
#706Tamper resistant dosage forms
#707Tamper resistant dosage forms
#708Tamper resistant dosage forms
#709Orodispersible tablets obtained by compression molding
#710Tamper resistant dosage forms
#711Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies
#712Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies
#713Pharmaceutical compositions and methods for fabrication of solid masses comprising immunoglobulins
#714Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins
#715Tablet composition comprising cinacalcet hydrochloride
#716ORAL FORM, COMPRISING IMMEDIATE-RELEASE COATED PARTICLES OF AT LEAST ONE ACTIVE COMPOUND THAT ARE GRINDING-RESISTANT
#717Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#718Solid unit with high fexofenadine content and process for the preparation thereof
#719Solid ganaxolone compositions and methods for the making and use thereof
#720Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#721Pharmaceutical composition for treatment of HIV infection
#722Pharmaceutical core-shell composite powder and processes for making the same
#723Dispersible Tablet
#724Rapidly dissolving pharmaceutical composition
#725High dose extended-release potassium citrate wax matrix tablet
#726MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#727Tamper resistant dosage forms
#728Tamper resistant dosage forms
#729Tamper resistant dosage forms
#730Controlled release hydrocodone formulations
#731Controlled release hydrocodone formulations
#732Controlled release hydrocodone formulations
#733CHEWABLE TABLETS COMPRISING LEVONORGESTREL
#734Dosage forms containing terbutaline sulphate
#735Abuse resistant drug formulation
#736NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
#737MINI-TABLETS
#738TAMPER-RESISTANT DOSAGE FORM COMPRISING PHARMACOLOGICALLY ACTIVE COMPOUND AND ANIONIC POLYMER
#739Naloxone mono preparation and multilayer tablet
#740Controlled release hydrocodone formulations
#741Pharmaceutical composition
#742Methods for making pharmaceutical solid dosage forms of spray-dried dispersions
#743CONTROLLED RELEASE FORMULATIONS AND PREPARATION METHOD THEREOF
#744Fast Dissolving Ocular Insert
#745Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#746Tamper-resistant oral opioid agonist formulations
#747Unitary pharmaceutical dosage form
#748Methylphenidate extended release chewable tablet
#749Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
#750Tablet formulation comprising semaglutide and a delivery agent
#751TABLETS FOR COMBINATION THERAPY
#752Controlled release hydrocodone formulations
#753Solid preparation
#754Pharmaceutical compositions of anti-viral compounds and process for preparation thereof
#755Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
#756Alfentanil composition for the treatment of acute pain
#757Water-insoluble, iron-containing mixed metal, granular material
#758Dry-coated tablet
#759Immediate Release Abuse-Deterrent Granulated Dosage Forms
#760Opioid agonist formulations with releasable and sequestered antagonist
#761Controlled release hydrocodone formulations
#762PHARMACEUTICAL COMPOSITION OF ENTECAVIR AND PROCESS OF MANUFACTURING
#763Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof
#764Pharmaceutical composition containing crystalline sorafenib tosylate
#765Compositions of GLP-1 peptides and preparation thereof
#766Tamper Resistant Dosage Form Composition And Process Of Making The Same
#767Tamper-resistant pharmaceutical dosage forms
#768Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
#769Controlled-release solid dosage forms of mesalamine
#770Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions
#771Process for the preparation of a solid, orally administrable pharmaceutical composition
#772Tamper resistant dosage forms
#773Tamper resistant dosage forms
#774Tamper resistant dosage forms
#775Controlled release hydrocodone formulations
#776Compositions comprising a delivery agent and preparation thereof
#777Tamper resistant immediate release formulations
#778Tamper resistant dosage forms
#779Modified release formulations containing drug—ion exchange resin complexes
#780Oral formulations of deferasirox
#781Dosage form comprising lopinavir and ritonavir
#782Controlled release and taste masking oral pharmaceutical composition
#783Matrix for sustained, invariant and independent release of active compounds
#784Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#785Pharmaceutical dosage form
#786Regimen for suppressing organ rejection
#787Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#788MULTIPLE UNIT PELLET TABLET FORMULATION COMPRISING AN OPIOID
#789Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
#790Immediate release formulations and dosage forms of gamma-hydroxybutyrate
#791Pharmaceutical compositions of lurasidone
#792Orally dispersible tablet containing compacted sildenafil base
#793Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#794TAMPER RESISTANT PHARMACEUTICAL FORMULATIONS
#795Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#796PHARMACEUTICAL COMPOSITIONS
#797Controlled release and taste masking oral pharmaceutical compositions
#798Controlled release and taste masking oral pharmaceutical compositions
#799Modified release compositions of epalrestat or a derivative thereof and methods for using the same
#800Pharmaceutical preparation containing oxycodone and naloxone
#801Solid dispersions of a ERB2 (HER2) inhibitor
#802Benzonatate modified release solid tablets and capsules
#803Sustained release formulation of nalbuphine
#804Tamper resistant dosage form comprising an adsorbent and an adverse agent
#805Modified release pharmaceutical compositions of dexlansoprazole
#806Oral formulations and lipophilic salts of methylnaltrexone
#807Solid, orally administrable pharmaceutical composition
#808SUSTAINED RELEASE MATRIX SYSTEMS FOR HIGHLY SOLUBLE DRUGS
#809Granular Pharmaceutical Composition
#810Tablet containing dehydroepiandrosterone (DHEA)
#811Orally disintegrating tablet compositions of lamotrigine
#812Solid Dosage Form
#813Reduction of opioid blood fluctuations
#814Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#815Direct Compression Formulation and Process
#816Pharmaceutical dosage form comprising polymeric carrier composition
#817Controlled release hydrocodone
#818CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#819Taste-masked pharmaceutical compositions containing diclofenac
#820Solid dosage forms of oleyl phosphocholine
#821Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
#822Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C
#823Bromocriptine formulations
#824SOLID PREPARATION
#825Melatonin treatment methods
#826Controlled-release melatonin compositions and related methods
#827Pharmaceutical composition containing diamine derivative
#828Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
#829Methods and compositions for self-regulated release of active pharmaceutical ingredient
#830Solid ganaxolone compositions and methods for the making and use thereof
#831Pharmaceutical composition
#832Antifungal compositions with improved bioavailability
#833Modified release formulations containing drug-ion exchange resin complexes
#834Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
#835Tamper-resistant oral opioid agonist formulations
#836CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#837Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein
#838Modified release tranexamic acid formulation
#839Compressed chewing gum tablet
#840Modified release compositions comprising tacrolimus
#841Modified release compositions comprising tacrolimus
#842Modified release compositions comprising tacrolimus
#843Matrix for sustained, invariant and independent release of active compounds
#844STABILIZED TACROLIMUS COMPOSITION
#845Method and composition for pharmaceutical product
#846Unitary pharmaceutical dosage form
#847Tamper resistant dosage forms
#848Modified release formulations containing drug-ion exchange resin complexes
#849Controlled release formulations of levodopa and uses thereof
#850NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
#851Controlled release formulations of levodopa and uses thereof
#852Encased tamper resistant controlled release dosage forms
#853Encased tamper resistant controlled release dosage forms
#854Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
#855Oral Composition
#856Oral formulations and lipophilic salts of methylnal trexone
#857MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS
#858SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
#859Opiod agonist formulations with releasable and sequestered antagonist
#860Thermo-kinetic mixing for pharmaceutical applications
#861Controlled release hydrocodone formulations
#862Liquid ganaxolone formulations and methods for the making and use thereof
#863Pharmaceutical compositions of linezolid
#864Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
#865Pharmaceutical formulations comprising CCR3 antagonists
#866Tamper resistant dosage forms
#867Tamper resistant dosage forms
#868Tamper resistant dosage forms
#869Controlled release formulations of levodopa and uses thereof
#870Tamper resistant dosage forms
#871Tamper resistant dosage forms
#872Tamper resistant dosage forms
#873Threo-DOPS controlled release formulation
#874Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
#875Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
#876Preparation for improving solubility of poorly soluble drug
#877Parenteral formulations of dopamine agonists
#878Non-abusable pharmaceutical composition comprising opioids
#879Stable pharmaceutical compositions comprising a pyrimidine-sulfamide
#880Dosage formulation
#881Sustained release formulation of nalbuphine
#882Diversion-resistant microgranules and microtablets
#883Abuse resistant drug formulation
#884Enteric tablet
#885Orally disintegrating tablet compositions of lamotrigine
#886Tolvaptan solid dispersion and its preparation method
#887Composition for preventing or treating osteoporosis, and manufacturing method therefor
#888Sustained Release Pharmaceutical Compositions for Highly Water Soluble Drugs
#889PHARMACEUTICAL COMPOSITIONS COMPRISING PHOSPHATE BINDER, CALCIUM RECEPTOR-ACTIVE COMPOUND AND/OR ACTIVE VITAMIN D
#890Method For Producing Solid Pigment-Containing Film Coating Compositions In The Form Of Granules Based On Enteric Film Formers For Pharmaceutical Dosage Forms
#891SOLID DISPERSION COMPRISING AN ANTI-HIV AGENT
#892CO-CRYSTALS AND PHARMACEUTICAL FORMULATIONS COMPRISING THE SAME
#893Modified release formulations containing drug-ion exchange resin complexes
#894CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION
#895PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#896SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
#897Quick Dissolving, Long Acting Zinc Therapeutic Formulations
#898CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BRIVARACETAM
#899EXTENDED RELEASE FORMULATIONS OF DESVENLAFAXINE BASE
#900Pharmaceutical preparation comprising phenylalanine derivative